✦ LIBER ✦

Prochlorperazine as a doxorubicin-efflux blocker: phase I clinical and pharmacokinetics studies

✍ Scribed by K. S. Sridhar; A. Krishan; T. S. A. Samy; A. Sauerteig; L. L. Wellham; G. McPhee; R. C. Duncan; S. Y. Anac; B. Ardalan; P. W. Benedetto

Publisher: Springer
Year: 1993
Tongue: English
Weight: 751 KB
Volume: 31
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00685030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase i study of 4′-0-tetrahydropyrany

A phase i study of 4′-0-tetrahydropyranyladriamycin: Clinical pharmacology and pharmacokinetics

✍ Kasi S. Sridhar; T. S. Anantha Samy; Ram P. Agarwal; Robert C. Duncan; Pasquale 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 962 KB

Phase I and pharmacokinetic study of a s

Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors : The relation between pharmacokinetic property and toxicity

✍ Ruey-Long Hong; Yun-Long Tseng 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

## BACKGROUND. Compared with free drug, sterically stabilized liposomal drug has prolonged circulation time and, thereby, higher tumor selectivity and antitumor activity. The stability in plasma is an important consideration in the formulation of clinically useful liposomal drug. A Phase I study o

A phase I clinical and pharmacokinetic s

A phase I clinical and pharmacokinetic study of the oral and the oral/ intravenous administration of menogaril

✍ Geoffrey R. Weiss; Thomas D. Brown; John G. Kuhn; Daniel D. Hoff; Robert H. Earh 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 742 KB

Phase I clinical and pharmacology study

Phase I clinical and pharmacology study of 502U83 given as a 24-h continuous intravenous infusion

✍ Richard L. Schilsky; Mark J. Ratain; Linda Janisch; Nicholas J. Vogelzang; V. So 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 703 KB